Johnson&Johnson's MRI-safe indication for Cypher:
This article was originally published in Clinica
Johnson & Johnson has received for its drug-eluting stent, Cypher, US FDA approval for MRI to be performed on patients immediately following the device's implantation. Cypher recipients typically had to wait for two months post device implantation before being scanned. Undergoing a scan sooner further enhances the overall level and quality of health care for stent patients, said the company. The FDA's decision comes just weeks after it granted a similar approval to Boston Scientific for its drug-eluting stent, Taxus.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.